Cargando…
Production of Mass-Separated Erbium-169 Towards the First Preclinical in vitro Investigations
The $\beta^-$-particle-emitting erbium-169 is a potential radionuclide toward therapy of metastasized cancer diseases. It can be produced in nuclear research reactors, irradiating isotopically-enriched $^{168}$Er$_2$O$_3$. This path, however, is not suitable for receptor-targeted radionuclide therap...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Lenguaje: | eng |
| Publicado: |
2021
|
| Materias: | |
| Acceso en línea: | https://dx.doi.org/10.3389/fmed.2021.643175 http://cds.cern.ch/record/2803707 |